Holen Sie sich die Stockscreener-App
0.9598
1.04%
-0.0101
Handel nachbörslich:
.99
0.0302
+3.15%
Schlusskurs vom Vortag:
$0.9699
Offen:
$0.9505
24-Stunden-Volumen:
120.48K
Relative Volume:
1.85
Marktkapitalisierung:
$16.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.53M
KGV:
-0.2418
EPS:
-3.97
Netto-Cashflow:
$-39.93M
1W Leistung:
-14.30%
1M Leistung:
-17.97%
6M Leistung:
-23.52%
1J Leistung:
-42.53%
1-Tages-Spanne:
$0.9468
$0.995
1-Wochen-Bereich:
$0.9468
$1.12
52-Wochen-Spanne:
$0.9468
$2.02
Unity Biotechnology Inc Stock (UBX) Company Profile
Firmenname
Unity Biotechnology Inc
Sektor
Branche
Telefon
(650) 416-1192
Adresse
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Vergleichen Sie UBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.9598 | 16.17M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-11-16 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-01-04 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-11-10 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-06-28 | Hochstufung | Citigroup | Sell → Buy |
| 2021-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-16 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-08-18 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-08-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-08-17 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-28 | Eingeleitet | ROTH Capital | Buy |
| 2019-12-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-03-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Eingeleitet | Mizuho | Buy |
| 2018-05-29 | Eingeleitet | Citigroup | Buy |
| 2018-05-29 | Eingeleitet | Goldman | Neutral |
| 2018-05-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Unity Biotechnology Inc Aktie (UBX) Neueste Nachrichten
Unity Biotechnology stock hits 52-week low at $0.95 - Investing.com
Unity Biotechnology (NASDAQ:UBX) Trading Down 5.6% – What’s Next? - Defense World
Unity Biotechnology stock hits 52-week low at $1.1 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.1 By Investing.com - Investing.com UK
Unity Biotechnology stock hits 52-week low at $1.1 amid challenges - Investing.com Canada
Unity Biotechnology (FRA:9U90) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
Unity Biotechnology (STU:9U90) EV-to-Revenue : (As of Nov. 28, 2024) - GuruFocus.com
Finance Watch: Adcendo Pursues Proof-Of-Concept With $135m Series B Round - Citeline
Unity Biotechnology (FRA:9U90) Price-to-Operating-Cash-Flow : (As of Nov. 25, 2024) - GuruFocus.com
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace
Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com
Carisma Therapeutics (NASDAQ:CARM) vs. Unity Biotechnology (NASDAQ:UBX) Head-To-Head Comparison - Defense World
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Unity Biotechnology's CFO sells shares worth $175 - Investing.com India
Unity Biotechnology's chief legal officer sells shares worth $192 - Investing.com India
Unity Biotechnology's CFO sells shares worth $175 By Investing.com - Investing.com Canada
Unity Biotechnology's chief legal officer sells shares worth $192 By Investing.com - Investing.com Canada
Unity Biotechnology stock hits 52-week low at $1.15 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.15 By Investing.com - Investing.com Canada
Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth? - Simply Wall St
Unity Biotechnology Focuses on Promising DME Treatment - TipRanks
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewswire
Age-related Macular Degeneration Market Size is Set for Rapid - openPR
Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals - Yahoo Finance UK
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial - Ophthalmology Times
Empery Asset Management, LP Acquires Shares in Volcon Inc - Yahoo Finance UK
Empery Asset Management's Strategic Acquisition in Elevation Oncology - Yahoo Finance
Empery Asset Management's Strategic Reduction in Sharps Technology Inc - Yahoo Finance
To Reverse Aging’s Clock, Adjust the Cell’s Machinery - Genetic Engineering & Biotechnology News
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - GlobeNewswire
Unity Biotechnology (FRA:9U90) Cash Ratio : 3.85 (As of Jun. 2024) - GuruFocus.com
Jefferies Financial Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $432.00 - Defense World
Tri Locum Partners LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Epoch Investment Partners Inc. Increases Stake in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World
Symmetry Investments LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
American Century Companies Inc. Has $13.14 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Pacer Advisors Inc. Grows Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Meiji Yasuda Asset Management Co Ltd. Buys 33 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Longevity and Anti-Senescence Therapy Market Share, Size, Growth, and Forecast to 2031 - InsightAce Analytic
Inspire Investing LLC Acquires 2,936 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Uniti Group Inc [UNIT] stock was sold by Mudry Ronald J. at the price of US$0.11 million - Knox Daily
1,054 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Choreo LLC - Defense World
Quest Partners LLC Has $89,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Liquidia Corp faces renewed legal challenge from United Therapeutics By Investing.com - Investing.com Australia
Meeder Advisory Services Inc. Invests $36,000 in Uniti Group Inc. (NASDAQ:UNIT) - Defense World
Unity Software Inc. (NYSE:U) Shares Bought by Daiwa Securities Group Inc. - Defense World
Commonwealth Equity Services LLC Has $1.16 Million Position in Unity Software Inc. (NYSE:U) - Defense World
Court rules against United Therapeutics in Liquidia case - Investing.com India
Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Unity Biotechnology Inc-Aktie (UBX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sullivan Lynne Marie | CFO & Head of Corp. Dev. |
Nov 04 '24 |
Sale |
1.29 |
136 |
175 |
55,925 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Nov 04 '24 |
Sale |
1.29 |
149 |
192 |
24,723 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Aug 02 '24 |
Sale |
1.53 |
154 |
236 |
24,872 |
| Ghosh Anirvan | Chief Executive Officer |
Aug 02 '24 |
Sale |
1.53 |
604 |
924 |
76,325 |
| Sullivan Lynne Marie | CFO & Head of Corp. Dev. |
Aug 02 '24 |
Sale |
1.53 |
139 |
213 |
56,061 |
| Nguyen Alexander Hieu | Chief Legal Officer |
Jun 25 '24 |
Sale |
1.40 |
78 |
109 |
25,026 |
| Ghosh Anirvan | Chief Executive Officer |
Jun 25 '24 |
Sale |
1.40 |
1,214 |
1,700 |
76,929 |
| Sullivan Lynne Marie | CFO & Head of Corp. Dev. |
Jun 25 '24 |
Sale |
1.40 |
324 |
454 |
32,685 |
| Ghosh Anirvan | Chief Executive Officer |
May 02 '24 |
Sale |
1.55 |
603 |
935 |
78,143 |
| Ghosh Anirvan | Chief Executive Officer |
Feb 02 '24 |
Sale |
1.71 |
680 |
1,163 |
78,746 |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):